在初级全关节整形术中,用旋转血栓显微镜对血凝的影响:一项随机对照试验
Uzung Yoon1, David Beausang1, Elia Elia2
1Department of Anesthesiology, Sidney Kimmel Medical College, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
EClinicalMedicine
|July 30, 2025
概括
与安慰剂相比,预防性三胺酸 (TXA) 在关节整形术 (THA) 期间的纤维解析或血液损失没有显著差异. 这表明,对于没有现有的纤维解质问题的THA患者,TXA可能不会被例行指示.
科学领域:
- 麻醉学 麻醉学
- 整形外科手术 整形外科手术
- 血液学 血液学 血液学
背景情况:
- 特兰克萨姆酸 (TXA) 通常用于减少关节整形术 (THA) 中的血液损失.
- 在THA患者中,TXA对纤维解和血液损失的特定影响尚未得到广泛研究.
- 这项研究研究了TXA对纤维解和THA期间的血液损失的预防作用.
研究的目的:
- 为了确定预防性三胺酸 (TXA) 是否降低了关节整形手术 (THA) 患者的纤维解质和血液损失.
- 为了比较THA期间接受TXA和安慰剂的患者之间的血液凝结能力和临床结果.
主要方法:
- 这是一项双盲随机对照试验,涉及50名接受初级THA治疗的患者.
- 旋转性血栓形成仪 (ROTEM) 用于评估血液凝结能力 (NATEM和T-APTEM).
- 主要结局是纤维素分解的程度 (1小时内最大溶解>15%).
主要成果:
- 在TXA和安慰剂组之间没有观察到血液凝结率或纤维素分解 (ROTEM变量) 的显著差异.
- 在外科手术期间,没有患者出现纤维素分解.
- 临床结果,包括血液损失和血液学参数,在各组之间是相似的.
结论:
- 预防性TXA给药似乎对THA患者没有先前存在的纤维解质条件没有明确的医疗适应性.
- 使用ROTEM监测血液凝结率可以帮助指导高风险患者选择性使用TXA.
- 可能需要进一步的研究来确定在THA期间受益于TXA的特定患者亚组.
关键词:
这是一种抗纤维素分析剂.凝血是凝固的过程.纤维化解是一种纤维化解.旋转性血栓弹性测量 (Thromboelastometry) 是一种旋转式血栓弹性测量.整体关节整形术 关节整形术特兰克萨姆酸是什么意思更多相关视频
06:16Author Spotlight: Advancing Thrombolytic Testing by Integrating Flow Dynamics in In Vitro Models
Published on: April 19, 2024
1.1K
09:51The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
3.1K
相关概念视频
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
911
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
911
